Why Sarepta Therapeutics Is Soaring Today

After reporting first-quarter results, shares of Sarepta Therapeutics (NASDAQ: SRPT), a commercial-stage biotech focused on rare diseases, jumped 14% as of 3:40 p.m. EDT Friday.Here's a review of the key numbers from the first quarter:Looking beyond the financial statements, Sarepta also recently signed an exclusive partnership deal with Myonexus Therapeutics. The move expands the company's pipeline from 16 programs to 21.Continue reading

Topics:     srpt    sarepta   therapeutics      

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News